- €954.73m
- €875.97m
- €241.46m
- 93
- 11
- 69
- 60
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 148 | 163 | 188 | 209 | 241 |
Cost of Revenue | |||||
Gross Profit | 130 | 142 | 159 | 176 | 203 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 130 | 143 | 164 | 181 | 210 |
Operating Profit | 17.4 | 19.9 | 24.1 | 27.8 | 31.9 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 16.9 | 19.6 | 23.1 | 27.3 | 33 |
Provision for Income Taxes | |||||
Net Income After Taxes | 12.1 | 15.1 | 17.5 | 19.8 | 23.8 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 10.8 | 14.9 | 17.2 | 19.3 | 24 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 10.8 | 14.9 | 17.2 | 19.3 | 24 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.74 | 0.815 | 1.1 | 1.22 | 1.63 |
Dividends per Share |